Drug Usage
Conditions
Keywords
tracheal extubation, remifentanil
Brief summary
Elderly patients show different pharmacokinetic and pharmacodynamic variables and usually need smaller doses of anaesthetic drugs than younger patients. The purpose of this study was to investigate the optimal effect-site concentration of remifentanil for preventing cough during emergence in elderly patients under sevoflurane and remifentanil anesthesia.
Interventions
Remifentanil was maintained at predetermined effect-site concentration during the periextubation period (initial concentration: 1.8 ng/ml) in elderly patients (65-80 years) .
Anesthesia was maintained with sevoflurane with 1.5-2.0 vol% in air/50%oxygen mixture, and sevoflurane was adjusted to about 1.0 vol% 10 min before end of surgery.
Sponsors
Study design
Eligibility
Inclusion criteria
* ASA physical status I or II undergoing endoscopic sinus surgery or septoplasty under balanced anesthesia with sevoflurane and remifentanil
Exclusion criteria
* predicted difficult airway, body mass index \> 30 kg/m2, history of obstructive sleep apnoea chronic respiratory disease or coughing, current smokers patients angiotensin converting enzyme-inhibitors
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of cough | from end of surgery to 5 min after tracheal extubation | Number of cough or a strong and sudden contraction of the abdomen during periextubation periods |
Countries
South Korea